1 month Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand? Investor's Business Daily

Amgen stock rebounded Wednesday, shaking off “overdone” fears that its monthly weight-loss shot causes excessive bone mineral density loss.
The post Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand? appeared first on Inv…

Amgen (AMGN) · Eli Lilly (LLY)

1 month Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand? Investor's Business Daily

19 hours Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know Zacks

2 days Here’s Why Amgen (AMGN) Gained But Lagged the Market Today Zacks

2 days Eli Lilly, Novo Nordisk Stocks Rise. Only One Is Operating From a Position of Strength. Yahoo Finance

2 days Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It Zacks

2 days Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know Zacks

2 days Lilly’s Zepbound Receives FDA Approval for Sleep Apnea Zacks

2 days Eli Lilly, Novo Nordisk Stocks Rise. One of These Obesity Drugmakers Just Hit a Landmark. Yahoo Finance

2 days Stocks to Watch Monday: Honda, Novo Nordisk, Eli Lilly, Xerox Yahoo Finance

4 days Is Now a Good Time to Buy the Dip in Eli Lilly Stock? Yahoo Finance

5 days Eli Lilly’s Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive? Investor's Business Daily

5 days Stocks to Watch Friday: Trump Media, Novo Nordisk, Eli Lilly, Tesla Yahoo Finance

5 days Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture YouTube

5 days Nvidia, Eli Lilly lead Friday’s market cap stock movers Investing.com

5 days Amgen stock gains on Novo Nordisk’s weightloss drug blunder FXStreet

5 days There’s a New Obesity King The Wall Street Journal

5 days Eli Lilly: Improved Competitive Position In Obesity Market, But Strong Execution Is A Must Now Seeking Alpha

5 days LLY Stock Up as FDA Removes Mounjaro, Zepbound From Shortage List Zacks

5 days FedEx, Eli Lilly, Occidental rise premarket; Nike, Novo Nordisk fall Investing.com

5 days Novo Nordisk’s new weight-loss drug works better, but not as well as expected MarketWatch

5 days Novo Crashes After Obesity Drug Misses Lofty Expectations. Lilly, Viking And Amgen Surge. Investor's Business Daily

6 days Eli Lilly dips despite FDA confirming shortage of GLP-1 tirzepatide is over Investing.com

6 days IBD 50’s Hims & Hers Tumbles After FDA Pulls Lilly’s Weight-Loss Drug From Shortage List Investor's Business Daily

6 days FDA says Eli Lilly’s weight loss drug Zepbound is no longer in shortage CNBC

6 days Zealand Pharma And Eli Lilly: Strategic Focus On Weight Management And Future Outlook Seeking Alpha

1 week Eli Lilly’s Alzheimer’s treatment approved in China Investing.com

1 week Eli Lilly Alzheimer’s drug donanemab approved in China Investing.com

1 week Amgen (AMGN) Stock Moves -0.21%: What You Should Know Zacks

1 week Eli Lilly (LLY) Stock Moves -0.05%: What You Should Know Zacks

1 week NVS vs. LLY: Which Stock Should Value Investors Buy Now? Zacks

1 week 15 Billion Reasons to Love Eli Lilly Stock Right Now Yahoo Finance

1 week Eli Lilly: A Rare Buying Opportunity Seeking Alpha

1 week Viridian Stock Flashes A Bullish Sign In Its Eye-Disease Battle With Amgen Investor's Business Daily

1 week Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf? Investor's Business Daily

1 week EMA Panel Endorses Lilly’s Omvoh for Expanded Use in Crohn’s Disease Zacks

2 weeks Eli Lilly’s Manjaro gains on Novo Nordisk’s Wegovy in UK Investing.com

2 weeks Why Amgen (AMGN) is a Top Growth Stock for the Long-Term Zacks

2 weeks Eli Lilly Reports Positive Data From Late-Stage Breast Cancer Study Zacks

2 weeks Eli Lilly Stock Could Have a Huge Growth Catalyst in Early 2025 Yahoo Finance

2 weeks Amgen (AMGN) Stock Sinks As Market Gains: Here’s Why Zacks

2 weeks Eli Lilly (LLY) Stock Slides as Market Rises: Facts to Know Before You Trade Zacks

2 weeks Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly CNBC

2 weeks Eli Lilly to test obesity drugs to treat addiction in 2025, CEO says #shorts #weightloss #zepbound YouTube

2 weeks Eli Lilly to test obesity drugs for smoking, alcohol abuse – Bloomberg Investing.com

2 weeks Here’s Why Amgen (AMGN) is a Strong Value Stock Zacks

2 weeks Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock Zacks

2 weeks Oracle, AutoZone and Alaska Air fell premarket; Eli Lilly rose Investing.com

2 weeks Lilly Announces New $15B Stock Buyback Plan, Ups Dividend by 15% Zacks

2 weeks The Zacks Analyst Blog Highlights Eli Lilly, AbbVie, Gilead Sciences, Air T and Fossil Group Zacks

2 weeks Eli Lilly announces $15 billion buyback, dividend hike Investing.com

2 weeks Top Stock Reports for Eli Lilly, AbbVie & Gilead Sciences Zacks

The Stock Market News